Early detection of pertussis related activity by wastewater surveillance of Bordetella pertussis- and Bordetella parapertussis-associated DNA concentrations in Osaka, Japan.
{"title":"Early detection of pertussis related activity by wastewater surveillance of <i>Bordetella pertussis-</i> and <i>Bordetella parapertussis-</i>associated DNA concentrations in Osaka, Japan.","authors":"Koichiro Suzuki, Daisuke Motooka, Naomi Sakon, Kazunori Tomono","doi":"10.1080/22221751.2026.2717860","DOIUrl":null,"url":null,"abstract":"<p><p>Pertussis causes recurrent outbreaks worldwide. Clinical surveillance can be affected by healthcare-seeking behaviour, diagnostic practices, testing sensitivity, and reporting delays. This study evaluated the utility of wastewater surveillance (WWS) by quantifying <i>Bordetella-</i>associated <i>IS481</i> and <i>IS1001</i> DNA concentrations. Weekly wastewater samples were collected from four treatment plants in Osaka Prefecture, Japan, between April 2023 and July 2025, and <i>IS481</i>- and <i>IS1001</i>-associated DNA concentrations were measured using quantitative PCR. The putative <i>B. pertussis</i>-associated <i>IS481</i> DNA concentration increased markedly from 2024 onwards. Both threshold-based onset detection and cross-correlation analysis indicated that the wastewater <i>IS481</i> DNA concentration preceded reported cases by one to several months. In contrast, the <i>B. parapertussis-associated IS1001</i> DNA concentration exhibited a transient peak in 2023, which aligned with contemporaneous clinical reports but remained at low levels thereafter. These findings suggest that WWS may detect increases in pertussis-related activity earlier than clinical reporting and highlight the potential of WWS as a complementary tool to clinical surveillance for monitoring respiratory infectious diseases.</p>","PeriodicalId":11602,"journal":{"name":"Emerging Microbes & Infections","volume":" ","pages":"2717860"},"PeriodicalIF":7.0000,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13495037/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Emerging Microbes & Infections","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/22221751.2026.2717860","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/19 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Pertussis causes recurrent outbreaks worldwide. Clinical surveillance can be affected by healthcare-seeking behaviour, diagnostic practices, testing sensitivity, and reporting delays. This study evaluated the utility of wastewater surveillance (WWS) by quantifying Bordetella-associated IS481 and IS1001 DNA concentrations. Weekly wastewater samples were collected from four treatment plants in Osaka Prefecture, Japan, between April 2023 and July 2025, and IS481- and IS1001-associated DNA concentrations were measured using quantitative PCR. The putative B. pertussis-associated IS481 DNA concentration increased markedly from 2024 onwards. Both threshold-based onset detection and cross-correlation analysis indicated that the wastewater IS481 DNA concentration preceded reported cases by one to several months. In contrast, the B. parapertussis-associated IS1001 DNA concentration exhibited a transient peak in 2023, which aligned with contemporaneous clinical reports but remained at low levels thereafter. These findings suggest that WWS may detect increases in pertussis-related activity earlier than clinical reporting and highlight the potential of WWS as a complementary tool to clinical surveillance for monitoring respiratory infectious diseases.
期刊介绍:
Emerging Microbes & Infections is a peer-reviewed, open-access journal dedicated to publishing research at the intersection of emerging immunology and microbiology viruses.
The journal's mission is to share information on microbes and infections, particularly those gaining significance in both biological and clinical realms due to increased pathogenic frequency. Emerging Microbes & Infections is committed to bridging the scientific gap between developed and developing countries.
This journal addresses topics of critical biological and clinical importance, including but not limited to:
- Epidemic surveillance
- Clinical manifestations
- Diagnosis and management
- Cellular and molecular pathogenesis
- Innate and acquired immune responses between emerging microbes and their hosts
- Drug discovery
- Vaccine development research
Emerging Microbes & Infections invites submissions of original research articles, review articles, letters, and commentaries, fostering a platform for the dissemination of impactful research in the field.